Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

327 projects found matching your search criteria :

  1. INVADOPODIA IN AXL-DRIVEN CANCER INVASION AND DRUG RESISTANCE

    Call: OPUS 25 , Panel: NZ3

    Principal investigator: dr Daria Paulina Zdżalik-Bielecka

    Uniwersytet Warszawski, Wydział Biologii

  2. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polska Akademia Nauk

  3. Designing Active Inhibitors of SARS-CoV-2 Methyltransferases

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Alex Jun Matsuda

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  4. Decrypting the "sulfation code" of glycosaminoglycans for understanding their function in the extracellular matrix

    Call: OPUS 25 , Panel: ST4

    Principal investigator: dr hab. Sergey Samsonov

    Uniwersytet Gdański, Wydział Chemii

  5. Chemosensors with molecularly imprinted polymers for determination of antiviral active drug substances in body fluids - ...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr Krzysztof Robert Noworyta

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  6. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

    Uczelnia Łazarskiego

  7. Effect of the chronic treatment with lamotrigine on changes in expression of genes related to seizure processes in the s...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Kinga Katarzyna Borowicz

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  8. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C...

    Call: PRELUDIUM BIS 4 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  10. Hybrid materials responsive to external stimuli for local drug delivery in endometriosis treatment - analysis of selecte...

    Call: SONATA 18 , Panel: ST5

    Principal investigator: dr Olga Urbanek-Świderska

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  11. Digital tools in L2 and L3 vocabulary acquisition. A cross-linguistic investigation

    Call: OPUS 24 (LAP) , Panel: HS2

    Principal investigator: dr hab. Agnieszka Maria Otwinowska-Kasztelanic

    Uniwersytet Warszawski, Wydział Neofilologii

  12. Computational deciphering of pro-ferroptotic cell death protein machinery as a fundamental step in the search for therap...

    Call: SONATA BIS 12 , Panel: ST4

    Principal investigator: dr hab. Karolina Anna Mikulska-Rumińska

    Uniwersytet Mikołaja Kopernika, Wydział Fizyki, Astronomii i Informatyki Stosowanej

  13. Regulatory network and interactome of inner membrane drug/metabolite transporters in bacteria – implications for physiol...

    Call: OPUS 23 , Panel: NZ2

    Principal investigator: dr hab. Aneta Agnieszka Bartosik

    Instytut Biochemii i Biofizyki PAN

  14. Role of the PARP1/HPF1 complex in the conferring of resistance to doxorubicin in triple negative breast cancer

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Magdalena Alicja Strachowska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  15. In search of the neural signature of a native and a second language. Using fMRI to investigate a relationship between a ...

    Call: PRELUDIUM 21 , Panel: HS6

    Principal investigator: Agata Jadwiga Wolna

    Uniwersytet Jagielloński, Wydział Filozoficzny

  16. Role of natural products in overcoming drug resistance in Mycobacterium tuberculosis

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Elwira Zofia Sieniawska

    Uniwersytet Medyczny w Lublinie

  17. Dysfunction of NFE2L1 and other family members causes damage in dopaminergic neuron function through dysregulated transc...

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Kamila Łuczyńska

    Instytut Genetyki i Hodowli Zwierząt PAN

  18. In Dialogue with the Extreme. The Reception of Paul Celan in the Italian Poetry from the mid-20th Century

    Call: OPUS 23 , Panel: HS2

    Principal investigator: dr hab. Alessandro Baldacci

    Uniwersytet Warszawski, Wydział Neofilologii

  19. Patchwork Parliaments. Post-imperial Field of Power in the Second Republic of Poland, Greater Romania and the Kingdom of...

    Call: OPUS 23 , Panel: HS6

    Principal investigator: dr Wiktor Henryk Marzec

    Uniwersytet Warszawski, Instytut Studiów Społecznych im. prof. Roberta B. Zajonca

  20. Reserved antibiotics and critical priority pathogens in hospital wastewater as an indicator of sanitary-epidemiological ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Ewa Korzeniewska

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

  21. Enzyme Responsive Nanoscale Supramolecular Capsules with Application in Anticancer Drug Delivery

    Call: POLONEZ BIS 2 , Panel: ST4

    Principal investigator: dr Venkateswarulu Mangili

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Zaawansowanych Technologii

  22. The application of artificial intelligence to the discovery of new natural drugs with mechanisms aimed at lowering free ...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Maciej Spiegel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

  23. MOF-antidote": Novel detoxification materials based on metal organic-frameworks for drugs of abuse removal - synthesis, ...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Przemysław Jakub Jodłowski

    Politechnika Krakowska im. Tadeusza Kościuszki

  24. Biological roles of transcriptional networks activated in the brain by psychotropic drugs

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Michał Korostyński

    Instytut Farmakologii PAN

  25. The role of Candida albicans' plasma membrane sphingolipids in the potentially new mechanism of drug resistance and in t...

    Call: OPUS 22 , Panel: NZ1

    Principal investigator: dr hab. Anna Janina Krasowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  26. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  27. Cinemagoing in German-occupied Poland: Cinema programming and film preferences of multi-ethnic urban audiences during Wo...

    Call: OPUS 22 , Panel: HS2

    Principal investigator: dr hab. Andrzej Dębski

    Uniwersytet Wrocławski, Centrum Studiów Niemieckich i Europejskich im. Willy Brandta

  28. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Call: OPUS 22 , Panel: NZ6

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

  29. Non-canonical pre-mRNA splicing participates in the editing of CNBP mutant allele in myotonic dystrophy type 2 (DM2)

    Call: PRELUDIUM BIS 3 , Panel: NZ1

    Principal investigator: dr hab. Marzena Wojciechowska

    Instytut Chemii Bioorganicznej PAN

  30. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii PAN

  31. Analysis of semaphorin 3 (SEMA3), protocadherin 9 (PCDH9) and S 100 calcium binding proteinA3 (S100A3) expression in pro...

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: dr hab. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

  32. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Szymon Tomczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  33. Nationwide Survey of 19-year old adult Polish men: Intergenerational changes of biological traits in relation to socio-e...

    Call: OPUS 21 , Panel: HS3

    Principal investigator: prof. Sławomir Marek Kozieł

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  34. IFIT proteins in the regulation of inflammatory responses

    Call: OPUS 21 , Panel: NZ2

    Principal investigator: dr Maria Wiktoria Górna

    Uniwersytet Warszawski, Wydział Chemii

  35. Evaluation of NOTCH1- and NOTCH3-dependent anticancer drug resistance in a 2D and 3D model of Head and Neck Squamous Cel...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: dr Joanna Elżbieta Kałafut

    Uniwersytet Medyczny w Lublinie

  36. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  37. Phonation in L1 and L2 speech

    Call: OPUS 21 , Panel: HS2

    Principal investigator: dr hab. Geoffrey Schwartz

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Anglistyki

  38. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to ...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Janusz Edward Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  39. Novel BODIPY derivatives and ruthenium complexes conjugates as photosensitizers for bacterial inactivation in the in viv...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Weronika Porolnik

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  40. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Anna Karolina Pogorzelska

    Narodowy Instytut Leków

  41. Development of methods of isotope-labeled standards preparation for their quantitative analysis by LC-MS in selected dru...

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Paulina Zamiara

    Uniwersytet Wrocławski, Wydział Chemii

  42. Benchmarking Human Tissue Culture Systems that Mimic the Tumor Microenvironment

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Matthias Nees

    Uniwersytet Medyczny w Lublinie

  43. Self-learning systems in the design of compounds modulating GPCR receptors activation.

    Call: OPUS 20 , Panel: NZ2

    Principal investigator: dr hab. Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

  44. AXL receptor signaling in cancer cell growth and drug resistance

    Call: OPUS 20 , Panel: NZ3

    Principal investigator: prof. Marta Elżbieta Miączyńska

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  45. Parallel quantitative evaluation of targetability, cellular uptake, and intracellular drug release for the establishment...

    Call: OPUS 20 (LAP) , Panel: ST5

    Principal investigator: prof. Adolfo Rivero Müller

    Uniwersytet Medyczny w Lublinie, Wydział Nauk Medycznych

  46. The role of vitamin D receptor in 5-fluorouracil responsiveness of colorectal cancer cells

    Call: SONATA 16 , Panel: NZ5

    Principal investigator: dr Magdalena - Milczarek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  47. The study on the molecular mechanisms of cytotoxic activity of new compounds ZOT5-1-Me and ZOT5-1-Et in an experimental ...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Paulina Anna Tokarz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  48. Delivery of immuno-activators to phagocytic cells in order to obtain an anti-tumor response

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  49. Entangled in common rights. The impact of conflicts over common rights and common lands on socio-economic changes in Wes...

    Call: SONATA 16 , Panel: HS3

    Principal investigator: dr Joachim Popek

    Uniwersytet Rzeszowski, Wydział Humanistyczny

  50. Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr Joanna Elżbieta Zawacka-Pankau

    Warszawski Uniwersytet Medyczny